A new compound that inhibits the activity of alertness-promoting brain peptides called orexins shows promise as a sleeping pill, according to tests in people and animals.
Men who took the drug fell asleep more quickly than did men who took a placebo, neurobiologist François Jenck of Actelion Pharmaceuticals in Allschwil, Switzerland, and his collaborators report in the February Nature Medicine.
Larger doses of the drug act faster and seem to have a stronger effect than do smaller doses, the researchers found. They previously observed similar effects in both dogs and rats.
Science News headlines, in your inbox
Headlines and summaries of the latest Science News articles, delivered to your email inbox every Thursday.
Thank you for signing up!
There was a problem signing you up.
The duration of drug-induced somnolence also depends on dose. The highest dose used in people caused drowsiness that lasted about 10 hours, the researchers report.
The drug, now known as ACT-078573, harnesses the 8-year-old discovery that insufficient orexin activity in the brain causes narcolepsy, a disorder of excessive sleepiness (SN: 8/14/99, p. 100: http://www.sciencenews.org/pages/sn_arc99/8_14_99/fob1.htm). Researchers have since theorized that an orexin-blocking drug might overcome insomnia.
Narcoleptic people experience sudden bouts of muscle weakness, called cataplexy. Jenck’s team found no signs of cataplexy as a side effect of the drug.